Abstract
The treatment of tinea versicolor in the past has been unsatisfactory. Recurrences were frequent despite prolonged daily applications of the medications available. A new compound, 9-aminoacridinium 4-hexylresorcinolate, in 3 topical vehicles (cream, lotion, and aerosol spray), has been evaluated by clinical and laboratory criteria in a series of 40 patients with this mycotic infection. Good to excellent results were obtained in 39 patients. In 32 of these, complete clearing occurred after a single course of 4 to 8 weeks; in 7 others it occurred after a second similar course. Only one patient had poor results, with prompt recurrences after repeated courses. No signs of primary irritation or allergic sensitization were observed in any case, and acceptance by patients was excellent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
